Tools chosen: kalshi_direct kalshi_related earnings_data claude_news gdelt_news code_execution wikipedia

Sub-questions (Fermi decomposition)

Planner reasoning

This is a numeric corporate-metric question: Altria's full-year 2026 domestic cigarette shipment volume vs a 54.5B stick threshold. The key is Altria's 2025 base volume (reported ~Jan/Feb 2026) and the recent annual decline rate (roughly -8% to -12% per year in recent years), so I need the reported volume history and guidance plus the Kalshi ladder of thresholds to read the market's implied distribution.

# Current state This is a threshold market on Altria's full-year 2026 reported domestic cigarette shipment volume. It resolves based on Altria's official 2026 full-year results (reported ~Jan/Feb 2027, market closes March 2028 to allow for confirmation). Current Kalshi YES price of 89% implies the market sees it as likely but not certain that 2026 shipments exceed 54.5 billion sticks, based on 2025 actuals (~61.7B, down 10% YoY) and forward decline-rate expectations. # Timeline of key events - 2020: Domestic cigarette shipment volume ~101.4B sticks (confirmed, Yahoo Finance/10-K data). - 2021: Volume ~93.8B, down 7.5% YoY (confirmed, SEC 10-K FY2021). - 2022: Down 9.7% YoY, implying ~84.7B (confirmed, SEC 10-K FY2022). - 2023: Down 9.9% YoY, implying ~76.3B (confirmed, SEC 10-K FY2023). - 2024: Down 10.2% YoY, volume ~68.6B (confirmed, SEC 10-K FY2024). - 2025-Q1: Down 13.7% YoY (confirmed, Altria Q1 2025 press release). - 2025-Q2: Down 10.2% YoY (confirmed, Altria Q2 2025 release). - 2025-Q3: Down 8.2% YoY, partly offset by trade inventory build (confirmed, Altria Q3 2025 release). - 2025-Q4/FY: Down 7.9% (Q4) and 10.0% (full year); FY2025 volume ~61.7B sticks (confirmed, SEC 10-K FY2025, filed 2026). - 2026-01/02: Altria issued FY2026 adjusted EPS guidance of $5.56–$5.72 (later narrowed to $5.61–$5.72 in Q2 2026), citing continued volume pressure from e-vapor/illicit disposables and macro pressure on consumers (confirmed, Altria press releases/10-K exhibits). - 2026-07: Q2 2026 earnings reported; stock fell on results ("Why Altria Stock Is Sinking Today," Fool/Yahoo, 2026-07-30) — reported but specific 2026 cigarette volume figures not extracted in this research pass. - 2026-08: Multiple dividend/comparison analyst pieces on Altria vs. peers; no new volume disclosures surfaced (reported, generic). # Event Will Altria report above 54.5 billion domestic cigarette shipments for full-year 2026? # Outcomes to forecast - Yes (>54.5B sticks) - No (≤54.5B sticks) # Kalshi market anchor **YES = 89%** (current). 7-day change: −1pp. 30-day change: −6pp (was as high as 98%, low 86%). Avg daily volume: 858 contracts over 14 data points — moderate liquidity, modestly declining conviction over the past month. # Sub-question answers 1. **2020-2025 volumes**: ~101.4B (2020) → ~93.8B (2021) → ~84.7B (2022) → ~76.3B (2023) → ~68.6B (2024) → ~61.7B (2025E) [claude_news, citing Yahoo Finance/SEC 10-Ks]. 2. **Recent YoY decline rate**: 9.7% (2022), 9.9% (2023), 10.2% (2024), 10.0% (2025) — roughly stable in the 9.7–10.2% band over the last four years, not clearly accelerating; one code_execution model using slightly different base numbers flagged a possible acceleration to ~11.4%, but the primary 10-K figures suggest stabilization near 10% [claude_news; code_execution — conflicting, reconciled toward 10-K figures as primary]. 3. **FY2025 shipment volume**: Down 10.0% for the full year; quarterly declines were 13.7% (Q1), 10.2% (Q2), 8.2% (Q3), 7.9% (Q4) — a decelerating intra-year trend [Altria press releases, confirmed]. 4. **Drivers of decline**: Company attributes volume loss primarily to industry decline rate (driven by illicit flavored disposable e-vapor growth), retail share losses, and discretionary income pressure on adult consumers; calendar differences and trade inventory movements are secondary/partially offsetting factors (Q3 2025 saw inventory build offsetting some decline; full-year ex-inventory decline ~9.5%) [Altria 10-K/press releases]. 5. **Kalshi ladder implication**: Only this single threshold (54.5B) surfaced in research; no full ladder data retrieved to infer distribution shape beyond this one price point. 6. **2026 regulatory/pricing catalysts**: Research is silent on specific FDA menthol rule or excise tax actions for 2026; Altria's 2026 guidance explicitly cites "moderated e-vapor industry growth" and "increased macroeconomic uncertainty" as guidance inputs, implying management expects continued (not radically worsening) volume pressure [Altria Q2 2026 guidance, SEC filing]. # Key facts (high-confidence, factual) 1. [SEC 10-K FY2025] FY2025 domestic cigarette shipment volume down 10.0% YoY; ex-inventory decline ~9.5%. 2. [Altria Q4/FY2025 release] Q4 2025 decline was 7.9%, the smallest quarterly decline of the year. 3. [claude_news/10-Ks] Four-year decline rates: 9.7%, 9.9%, 10.2%, 10.0% — stable ~10% band. 4. [Kalshi] Current YES price 89%, down from a 30-day high of 98%. # Cross-market signals - Kalshi related: Only one KXMOA market surfaced (this one); no adjacent threshold rungs found for ladder comparison. - Polymarket: Not covered in research. - Sportsbook implied: N/A (not a sports event). # Analyst opinions and speculation - Motley Fool/Yahoo pieces (2026-07-30) note Altria stock "sinking" after Q2 2026 results — suggests some negative surprise, but no specific volume figure was extracted; could reflect earnings/guidance concerns broadly, not necessarily cigarette volume miss. - General analyst commentary (Fool "Better Buy" pieces) frames Altria as a stable, high-yield dividend stock managing structural volume decline via pricing, without alarm about a sudden decline-rate breakout. # Directional lean per outcome - **Yes (>54.5B)**: Supported by stable ~10% historical decline rate (vs. ~11.7% needed to breach threshold from a 61.7B 2025 base), decelerating quarterly declines through 2025 (Q4 only −7.9%), and current 89% Kalshi price. - **No (≤54.5B)**: Supported by structurally worsening illicit vape/disposable competition cited every quarter, discretionary income pressure, and the 6pp downward drift in Kalshi price over 30 days signaling some erosion of confidence; a repeat of the ~11%+ 2024 decline rate would risk crossing the threshold. # Gaps / unknowns - No confirmed 2026 actual or interim shipment data (2026 fiscal year not yet complete at close time; Q2 2026 earnings referenced but specific volume % not retrieved). - Full Kalshi ladder (other threshold rungs) not available to cross-check implied distribution. - No specific 2026 regulatory catalysts (FDA menthol, excise tax) confirmed in research. # Calibration anchors - Kalshi current YES price: 89% (primary anchor). - Historical base rate: decline needed to breach threshold (~11.7%) exceeds actual realized declines in 4 of the last 4 years (max was 10.2% in 2024), supporting a high but not extreme probability, consistent with Kalshi's 86-98% trading range.

1. Both forecasters compute the needed decline as ~11.7% but neither explicitly notes this is only ~1.5pp above the worst realized decline (10.2% in 2024) and ~1.7pp above the most recent full year (10.0%), which is a fairly thin margin given one data point (code_execution's flagged ~11.4% acceleration scenario) sits almost exactly at the threshold — this tail scenario deserves more explicit weight than a passing mention. 2. Neither forecast substantively engages with the Q2 2026 stock-price decline ("Why Altria Stock Is Sinking Today") despite it being the only actual 2026-vintage data point in the brief; Forecast 1 mentions it only to justify a small downward shade, and Forecast 2 dismisses it without analysis, but this could plausibly reflect a volume/guidance miss directly relevant to the threshold. 3. Both anchor tightly to the 89% Kalshi price without independently stress-testing the "ex-inventory" ~9.5% decline figure — if 2025's headline 10.0% was partly inflated by trade inventory dynamics reversing unfavorably in 2026, the true underlying decline rate could be closer to 9.5-10.5%, actually reducing breach risk, which would argue for higher confidence than either forecaster shows, not lower. 4. Neither discusses the compounding/base-effect nonlinearity: since the threshold is defined in absolute sticks (54.5B) from a moving base, if 2026 starts lower due to any Q1 2026 acceleration (as historically Q1 tends to show the steepest YoY decline, e.g., -13.7% in Q1 2025), the full-year outcome is disproportionately sensitive to early-2026 trends that aren't reported in the brief at all — this is a real gap neither model flags as a specific unknown driving variance. 5. The 30-day Kalshi drift from 98% to 89% (a 9pp drop, not just the 6pp cited) suggests something specific moved the market recently, and both forecasters treat this as vague "erosion of confidence" rather than seeking the proximate cause (e.g., Q2 2026 earnings), which is a missed diagnostic opportunity that could sharpen the probability materially in either direction. 6. Both converge to nearly identical final probabilities (86% and 89%) despite ostensibly different reasoning approaches, suggesting insufficient independent stress-testing of the Kalshi anchor — an outside-view check (e.g., using the standard deviation of the 4-year decline-rate sample, which is quite small at ~0.2pp, implying a much narrower distribution and possibly higher confidence than 86-89%) is absent from both.

88% (62% confidence)

Yes: 88% No: 12%

Breaching 54.5B from a ~61.7B FY2025 base requires a ~11.7% decline in 2026, larger than any of the last four realized annual declines (9.7%, 9.9%, 10.2%, 10.0%), whose dispersion is remarkably tight (~0.2pp SD). That tight historical dispersion argues for a fairly confident Yes, but true forward uncertainty is wider than the backward sample suggests given escalating illicit disposable-vape competition, macro pressure on consumers, and the fact that Q1 declines have historically been steepest (−13.7% in Q1 2025). The one genuine 2026-vintage signal — the Q2 2026 stock drop plus Kalshi's drift from 98% to 89% — plausibly reflects some real deterioration the brief could not quantify, which offsets the ex-inventory argument (~9.5% underlying 2025 decline) that would otherwise push probability higher. I settle essentially at the market anchor, 88.5% Yes, between the two forecasts and consistent with the 86–98% trading range.

Total pipeline time: 275.0s